Damn liver

guntruck

New member
Well fellas not that nayone cares but I went to get my blood work done prior to my cycle that was suppose to start on june first. Well results were good but doc says liver results were a little high, he says that 1 beer and as little as two advil could make it jump so he wants to retest to make sure its not constantly high. He said its not real high just a little. My dilemma is do I let them take my blood tomorrow then start my cycle the following monday, because if its still high they may wanna do more test and then I'll be "on" which is no good and once I start i aint stoppin =). Or wait for the results which will either be the same or better news that its all good but then it will be like 3 more freakin weeks. Decisions decisions =) Oh well we'll see Im still thinking about it. The cycles only gonna stress the liver a little more for 10 wks , I'll just lay off the boo's :D :D :D
 
Most standard blood tests for liver contain SGOT/SGPT. In athletes these values may be elvated solely from training,a gamma glutamyl transferase level(GGT) is the only real test you need as a screen for liver and AAS,the others may be falsely elevated...causing unnecessary concern for you and unnecessary further testing from your Doc. This article gives a concise explanation.

Clin J Sport Med 1999 Jan;9(1):34-9 (ISSN: 1050-642X)
Dickerman RD; Pertusi RM; Zachariah NY; Dufour DR; McConathy WJ
The Department of Biomedical Science, University of North Texas Health Science Center, Fort Worth 76107-2699, USA.
OBJECTIVE: There have been numerous reports of hepatic dysfunction secondary to anabolic steroid use based on elevated levels of serum aminotransferases. This study was conducted to distinguish between serum aminotransaminase elevations secondary to intense resistance training and anabolic steroid-induced hepatotoxicity in elite bodybuilders. DESIGN: This was a case-control study of serum chemistry profiles from bodybuilders using and not using anabolic steroids with comparisons to a cohort of medical students and patients with hepatitis. PARTICIPANTS: The participants were bodybuilders taking self-directed regimens of anabolic steroids (n = 15) and bodybuilders not taking steroids (n = 10). Blood chemistry profiles from patients with viral hepatitis (n = 49) and exercising and nonexercising medical students (592) were used as controls. MAIN OUTCOME MEASURES: The focus in blood chemistry profiles was aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltranspeptidase (GGT), and creatine kinase (CK) levels. RESULTS: In both groups of bodybuilders, CK, AST, and ALT were elevated, whereas GGT remained in the normal range. In contrast, patients with hepatitis had elevations of all three enzymes: ALT, AST, and GGT. Creatine kinase (CK) was elevated in all exercising groups. Patients with hepatitis were the only group in which a correlation was found between aminotransferases and GGT. CONCLUSION: Prior reports of anabolic steroid-induced hepatotoxicity based on elevated aminotransferase levels may have been overstated, because no exercising subjects, including steroid users, demonstrated hepatic dysfunction based on GGT levels. Such reports may have misled the medical community to emphasize steroid-induced hepatotoxicity when interpreting elevated aminotransferase levels and disregard muscle damage. For these reasons, when evaluating hepatic function in cases of anabolic steroid therapy or abuse, CK and GGT levels should be considered in addition to ALT and AST levels as essential elements of the assessment.
 
Back
Top